Literature DB >> 15201163

Genetic factors in cardiac hypertrophy.

Gerald W Dorn1, Harvey S Hahn.   

Abstract

Cardiac hypertrophy is an adaptive response to any cardiac insult or stress that increases hemodynamic load. Cardiac hypertrophy can exist in a state of compensation or progress to a decompensated state (i.e., heart failure) over time. It has been established through transgenic overexpression and gene ablation studies that multiple signaling pathways are involved in the induction of hypertrophy as well as its decompensation. This article reviews the role of G alpha q in the development of pressure overload hypertrophy and discusses the relationships between G alpha q and beta-adrenergic receptors, RGS proteins, and the proapoptotic factor, Nix/Bnip3L.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201163     DOI: 10.1196/annals.1302.019

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.

Authors:  Sudeshna Fisch; Susan Gray; Stephane Heymans; Saptarsi M Haldar; Baiqiu Wang; Otmar Pfister; Lei Cui; Ajay Kumar; Zhiyong Lin; Sucharita Sen-Banerjee; Hiranmoy Das; Christine A Petersen; Ulrike Mende; Barbara A Burleigh; Yan Zhu; Yigal M Pinto; Yigal Pinto; Ronglih Liao; Mukesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

2.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

Authors:  Yunhui Cheng; Ruirui Ji; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

3.  Ameliorate Effects of Li-Fu Formula on IL-6-Mediated Cardiac Hypertrophy in Hamsters Fed with a Hyper-Cholesterol Diet.

Authors:  Yi-Chang Cheng; Chieh-His Wu; Wei-Wen Kuo; James A Lin; Hsueh-Fang Wang; Fuu-Jen Tsai; Chang-Hai Tsai; Chih-Yang Huang; Tsai-Ching Hsu; Bor-Show Tzang
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

4.  RhoGEF12 controls cardiac remodeling by integrating G protein- and integrin-dependent signaling cascades.

Authors:  Mikito Takefuji; Marcus Krüger; Kishor K Sivaraj; Kozo Kaibuchi; Stefan Offermanns; Nina Wettschureck
Journal:  J Exp Med       Date:  2013-03-25       Impact factor: 14.307

Review 5.  miRNA regulation during cardiac development and remodeling in cardiomyopathy.

Authors:  K L Chaitra; Kayalvili Ulaganathan; Anita James; Venkateshwari Ananthapur; Pratibha Nallari
Journal:  EXCLI J       Date:  2013-11-26       Impact factor: 4.068

Review 6.  Deregulation of RGS2 in cardiovascular diseases.

Authors:  Sharon Tsang; Anthony Yiu-Ho Woo; Weizhong Zhu; Rui-Ping Xiao
Journal:  Front Biosci (Schol Ed)       Date:  2010-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.